2021
S122 Effectiveness of Gemcitabine Plus S-1 Combination As First-Line Therapy Tested in Japanese Population for Advanced Biliary Tract Cancer: Systematic Review of Clinical Trials
Ahmed F, Nasr U, Susheela A, Zakaria F, Ali S, Hamdan A, Sajja A, Andrews K, Bobba S, Potla S, Aslam A, Mezidor M, Yukselen Z, Mohan K, Zarrar R, Shahini E, Muniraj T. S122 Effectiveness of Gemcitabine Plus S-1 Combination As First-Line Therapy Tested in Japanese Population for Advanced Biliary Tract Cancer: Systematic Review of Clinical Trials. The American Journal Of Gastroenterology 2021, 116: s51-s51. DOI: 10.14309/01.ajg.0000772960.67902.ee.Peer-Reviewed Original Research
2020
Constant-severe pain in chronic pancreatitis is associated with genetic loci for major depression in the NAPS2 cohort
Dunbar E, Greer PJ, Melhem N, Alkaade S, Amann ST, Brand R, Coté GA, Forsmark CE, Gardner TB, Gelrud A, Guda NM, LaRusch J, Lewis MD, Machicado JD, Muniraj T, Papachristou GI, Romagnuolo J, Sandhu BS, Sherman S, Wilcox CM, Singh VK, Yadav D, Whitcomb DC. Constant-severe pain in chronic pancreatitis is associated with genetic loci for major depression in the NAPS2 cohort. Journal Of Gastroenterology 2020, 55: 1000-1009. PMID: 32681239, PMCID: PMC9124361, DOI: 10.1007/s00535-020-01703-w.Peer-Reviewed Original ResearchConceptsConstant severe painRecurrent acute pancreatitisChronic pancreatitisDepression-associated genesCP patientsPain severityAntidepressant usePancreatitis patientsPain experienceProspective randomized trialsAntidepressant medication usePattern of painCase report formsChronic opioidsIslet autotransplantationAntidepressant therapyTotal pancreatectomyMedication usePain managementRandomized trialsCounseling patientsRetrospective studyAcute pancreatitisClinical trialsMajor depression